Cardio Diagnostics Holdings, Inc. current report, Q1 FY2023

Business Context and Reporting Period

Company: Cardio Diagnostics Holdings, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 8, 2023
Event: Entry into a Material Definitive Agreement (Securities Purchase Agreement) and creation of a direct financial obligation.

Key Financial Metrics and Transaction Details

The filing details a financing transaction rather than periodic financial performance metrics (revenue, profit, cash flow). Key transaction figures include:

  • Total Facility Size: Up to $11.2 million in principal amount of Convertible Debentures.
  • Initial Closing (First Convertible Debenture):
    • Principal Amount: $5.0 million
    • Purchase Price: $4.5 million
    • Interest Rate: 0.0% per annum (increases to 15% upon default).
    • Maturity: March 8, 2024 (12-month anniversary).
  • Second Tranche (Contingent):
    • Principal Amount: $6.2 million
    • Purchase Price: $5.58 million
    • Condition: Issued upon SEC declaration of effectiveness of the Initial Registration Statement.
  • Conversion Terms:
    • Conversion Price: Lower of $5.00 (Fixed) or 92% of the 7-day VWAP (Variable), with a floor of $0.55 per share.
    • Exchange Cap: Limited to 1,921,987 shares (19.99% of outstanding shares) unless stockholder approval is obtained.

Material Changes and Obligations

The primary material change is the incurrence of new debt and potential equity dilution:

  • Liquidity Impact: Immediate receipt of $4.5 million cash from the First Convertible Debenture.
  • Trigger Events: If the stock price falls below the $0.55 floor for 5 of 7 days, or if 99% of the Exchange Cap is reached, the Company must make monthly prepayments of $1 million plus a 10% premium and accrued interest.
  • Redemption Rights: The Company may redeem the debentures if the trading price is below the Fixed Conversion Price ($5.00), subject to a 10% premium.
  • Registration Rights: The Company must file a registration statement for the resale of up to 5,600,000 shares within 21 days of filing its 2022 10-K.

Outlook, Risks, and Contingencies

  • Banking Contingency: The Company confirmed it holds no deposits at Silicon Valley Bank. All accounts are held at a major money center bank, except for one regional bank account under $250,000 (fully FDIC insured).
  • Default Risk: Upon an event of default, the interest rate jumps to 15% per annum, and the full principal becomes immediately due and payable.
  • Dilution Risk: Conversion of the debentures could result in significant equity dilution, capped at 19.99% of outstanding shares without further stockholder approval.
  • Covenants: The Company is restricted from entering into variable rate transactions with other parties and must obtain consent for charter amendments affecting debenture holders.

Investor Verification Checklist

  • Verify the current trading price of CDIO relative to the $5.00 Fixed Conversion Price and $0.55 Floor Price to assess conversion likelihood and trigger risks.
  • Confirm the status of the Initial Registration Statement filing and its expected effectiveness date to determine if the second tranche ($6.2M) will be issued.
  • Review the Company's cash position post-closing to ensure ability to meet potential monthly prepayment obligations if a Trigger Event occurs.
  • Monitor the 10-K filing for the fiscal year ended December 31, 2022, to track the deadline for the registration statement.